<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The time window in the treatment of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> with tissue plasminogen activator (tPA) is narrow, arbitrarily within 3 hours after the <z:hpo ids='HP_0003674'>onset</z:hpo> of symptom </plain></SENT>
<SENT sid="1" pm="."><plain>Hemorrhagic transformation resulting from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> may be related to damage of the microvascular basal lamina of the brain, which may in turn cause microvascular <z:mpath ids='MPATH_179'>fibrin deposition</z:mpath> and aggravate <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we investigated the effect of tPA on the microvascular tissue changes during <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Sprague-Dawley rats were subjected to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> by ligation of the right middle cerebral artery and bilateral common carotid arteries for 90 minutes </plain></SENT>
<SENT sid="4" pm="."><plain>Sixty minutes after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, escalated dosages of tPA from 2.5 to 10 mg/kg or saline were intravenously infused for 60 minutes </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty-four hours after reperfusion, the animals were allowed to be killed for examination </plain></SENT>
<SENT sid="6" pm="."><plain>Low dosage of tPA (2.5-7.5 mg/kg) reduced post-ischemic <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, suppressed metalloproteinase 2 (MMP-2) activity and restored blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) integrity </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast, high dose of tPA (10 mg/kg) aggravated <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e>, increased MMP-2 activity and exacerbated <z:chebi fb="2" ids="33602">BBB</z:chebi> disruption </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo>/reperfusion decreased the immunoreactivity of both collagen type IV- and laminin-positive microvessels, whereas the low dosage of tPA (2.5-7.5 mg/kg) attenuated the reduction </plain></SENT>
<SENT sid="9" pm="."><plain>When these molecules in whole cortical tissues were analysed, tPA dosage-dependently decreased the total content of collagen type IV, laminin and fibronectin </plain></SENT>
<SENT sid="10" pm="."><plain>Although the detailed mechanisms regarding the action of tPA are yet to be investigated, our findings demonstrate that the detrimental effect of tPA was mediated, at least in part, through the destruction of the basal lamina in the cerebral microvessels by activating MMP-2 </plain></SENT>
</text></document>